• Patented proprietary raw ingredients; all products backed by clinical research
• Adheres to the Japanese Good Manufacturing Practices (GMPs) for pharmaceutical products
• Strategic planning, joint ventures, marketing and merchandising

Toyo Bio-Pharma™ is a research-driven manufacturer committed to providing consumers and clients with high-value products derived from nature, and contributing to society through research and products for better health. Toyo Shinyaku Co., Ltd., the parent company of Toyo Bio-Pharma, was established in Japan in 1997.

With more health products approved by FOSHU (Foods for Specified Health Use) than any other company, Toyo Bio-Pharma has now entered the U.S. market with its feature product, TOYO-FVG®. This unique water-extract, rich in OPC, contains more than twice the amount of most other pine bark extracts and 80% more polyphenol. It has superior efficacy and is more bioavailable; its recommended dosage is 30% less than the leading pine bark extracts.

Along with their competitive OPC product, TOYO-FVG, Toyo Bio-Pharma is a world leader in the field of fermentation, active in research, product development and manufacturing. Their core technologies include fermentation, selective culture and the botanical development. Bridging tradition and technology, Toyo Bio-Pharma is one of the few companies in the world to harness the power of fermentation on such a large industrial scale. The resulting health foods and nutraceuticals offer consumers unique products with enhanced potency and functionality.

Toyo Bio-Pharma has incredible capacity and expertise in manufacturing custom formulations, conducting laboratory tests and validating results. Toyo’s parent company, Toyo Shinyaku Co. Ltd., is Japan’s largest developer and OEM producer of raw materials for food supplements. As such, Toyo Bio-Pharma is ideally situated to work with clients on a contract basis. Partnerships have resulted in patented and proven formulas that promote mutual success when advancing into new markets.

From raw material selection and procurement to the final filling and packaging, Toyo Bio-Pharma’s integrated production is the key to their manufacturing policy. Toyo works with its own growers to optimize cultivation and harvesting of raw materials. In the production facility, the core strengths of fermentation and selective culture are combined with solid capabilities in pulverizing, sterilizing and packaging.

The company follows the rigorous standards of ISO 9001:2000 and voluntarily applies the Good Manufacturing Practices established by the Japanese government for pharmaceutical products. Although very few of Toyo Bio-Pharma’s products belong in this category, the company has chosen to meet and exceed GMP production, management and quality control practices. After production is complete, Toyo Bio-Pharma exercises meticulous care in storage and distribution to ensure that all products retain their superior quality.